Clinical trials of new biologics in patients with inflammatory bowel disease (IBD), such as upadacitinib (Rinvoq), have shown promising results, with remission rates ...
Upadacitinib (UPA; Rinvoq) is an oral selective inhibitor for Janus kinase 1 approved for the treatment of tumor necrosis factor (TNF)-alpha-experienced patients with inflammatory bowel disease (IBD).
Verywell Health on MSN
Ulcerative colitis vs. Crohn's disease: What's the difference?
Medically reviewed by Robert Burakoff, MD Takeaway Ulcerative colitis usually affects the large intestine and causes continuous inflammation.Crohn's disease can affect any part of the digestive tract ...
Inflammatory bowel disease (IBD) is a chronic condition with significant health implications worldwide. In Nigeria, data on its prevalence and characteristics are limited, highlighting the need for ...
Infectious colitis is an inflammatory condition caused by bacteria, a virus, or a parasite. It can cause diarrhea and other symptoms. Treatment will depend on the cause. Infectious colitis causes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results